Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic ...

Ann Foster's journey into nursing was inspired by her husband's cancer battle, leading her to pursue her childhood dream.

Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of ...

Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact ...

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 ...

After testicular cancer, I’ve learned to guard my mood, seek small joys and embrace healing and renewal with every sunrise ...

Enrollment and initial dosing of PAS-004 at 30 milligrams has begun in three patients with MAPK pathway-driven advanced solid ...

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following ...

A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following ...

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...